Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. - Wikidata - awgldk - TriplyDB

Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.

Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.

http://www.wikidata.org/entity/Q45125308

about

The adipocyte-expressed forkhead transcription factor Foxc2 regulates metabolism through altered mitochondrial function The C. elegans Opa1 homologue EAT-3 is essential for resistance to free radicals The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment OPA1-related auditory neuropathy: site of lesion and outcome of cochlear implantation.Heterozygous mutation of Drosophila Opa1 causes the development of multiple organ abnormalities in an age-dependent and organ-specific manner Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity.Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data.Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy.Heterozygous mutation of Opa1 in Drosophila shortens lifespan mediated through increased reactive oxygen species production.OPA1-related dominant optic atrophy is not strongly influenced by mitochondrial DNA background.Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex Variation in OPA1 does not explain the incomplete penetrance of Leber hereditary optic neuropathy.Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes.Mitochondrial oxidative phosphorylation compensation may preserve vision in patients with OPA1-linked autosomal dominant optic atrophy.Mitochondrial remodeling following fission inhibition by 15d-PGJ2 involves molecular changes in mitochondrial fusion protein OPA1.Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.Mitochondrial localization of telomeric protein TIN2 links telomere regulation to metabolic control Mitochondrial dynamics in cancer and neurodegenerative and neuroinflammatory diseases.Skeletal muscle mitochondria and aging: a review.Emerging functions of mammalian mitochondrial fusion and fission.A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies.Modeling autosomal dominant optic atrophy using induced pluripotent stem cells and identifying potential therapeutic targets Mitochondria at the synapse.Mitochondrial energetics and insulin resistance.Inherited mitochondrial optic neuropathies.Acute and late-onset optic atrophy due to a novel OPA1 mutation leading to a mitochondrial coupling defect.Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency Mitochondrial OPA1, apoptosis, and heart failure.Disturbed mitochondrial dynamics and neurodegenerative disorders.Mitochondrial Dynamics and Heart Failure.Insulin Resistance and Mitochondrial Dysfunction.Secondary mtDNA defects do not cause optic nerve dysfunction in a mouse model of dominant optic atrophy.The OPA1 Gene Mutations Are Frequent in Han Chinese Patients with Suspected Optic Neuropathy.High-resolution en face images of microcystic macular edema in patients with autosomal dominant optic atrophy.OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy.Altered skeletal muscle mitochondrial biogenesis but improved endurance capacity in trained OPA1-deficient mice.Impaired quality of life in growth hormone-deficient adults is independent of the altered skeletal muscle oxidative metabolism found in conditions with peripheral fatigue.Novel OPA1 missense mutation in a family with optic atrophy and severe widespread neurological disorder.OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.Monitoring clinical progression with mitochondrial disease biomarkers.

P2860

Q24633432-0AD9B914-A3D7-4DCA-A47D-25C13C8F4C6D Q27314280-B2F8C411-871E-41BD-9948-68539453D531 Q27314564-D1544928-A545-4BDB-B9CD-086746201421 Q28255026-FBF868B0-4C7D-4A61-81DB-F54E85B2E756 Q28476042-35EC0B07-DA71-4337-BF8C-8C2A65469CE3 Q30532888-7E0BDFFD-D61F-449C-AF63-1805E3CB16A8 Q30854410-F38AF4C7-EDE9-4154-9D2C-FFDE336B16E9 Q33368476-3D16CE1C-F94E-418D-A727-1DDFAC7AB666 Q33409839-5D503232-018C-4A1C-B0E3-4216DDF7AA49 Q33484390-17892D52-BC86-452C-963C-8FC808AF3AA4 Q33779586-1E40CBF4-7342-4E33-B5FF-727D2770C957 Q33784359-9A0DEB9D-0311-4B14-BD1A-311240049799 Q33940901-7DE63664-7584-4B2D-95F4-E23E1668B41C Q33952321-DE13A7E1-EE03-4903-B0DC-20D2BEB2449A Q34140497-C129AECF-4DFE-458C-8298-5B4CF503551B Q34152110-AAFA3E27-0165-40D6-B9AE-1B2F70107D87 Q34293477-C534ECA0-9EE4-4D4F-81BC-300CB3EDDD8E Q36082495-D5BF6A8B-F281-4506-A701-3704A8643A67 Q36128733-897A6083-D783-4729-97CA-A65736936319 Q36294710-98D2E143-9550-46EF-AFD4-AAFAB0F3C2CD Q36373032-C67EE97F-2332-4290-A08C-4BC0A98B9F61 Q36439203-A94214C4-A8CF-4E5E-B580-7257EAA60ECA Q36535662-D47EA736-7802-4938-A531-954629A7FAF9 Q37059505-EE4207F0-D82B-4DFA-A361-33E397DC2C32 Q37098009-7D7B031E-63B8-459C-98EA-2C1497C3FE9D Q37140630-0EE473F1-AE3D-41AC-9624-B06497FEE51B Q37215027-2138FCCC-AA98-4219-BFBA-5A98613107FD Q37341059-B367902D-D9AB-4EDE-BD9E-5E673FDC1894 Q38285228-D5ECD26E-4125-4147-A53B-3F9FB5267296 Q38693299-9EAD7317-85B5-4BD6-AAE8-F5BFEF597B67 Q39334553-9D7C55FB-A5CB-4D7A-8F0E-5F23E0F9C220 Q39951945-F931EC54-B0DA-489D-8B2A-BE76E57BEC31 Q40004279-35E4D2FA-1217-47DB-B7B4-9F12CBFE5EF0 Q42181628-4E88FA04-A554-44F7-BAE8-756DCE1E105F Q42709140-ED974AB4-A3D5-4F88-8D55-6CA6D1927B03 Q44021367-A5AF0C90-B9E4-43F1-A051-9B83E4D04276 Q44393951-16D001CE-7E6B-40C7-A3DB-53275A37EF3B Q46582942-8652FA99-0F05-41CA-90E9-7CD29FBCF85B Q46789094-00A13349-4B92-4AAC-BAB1-47BD2FC175F4 Q47713915-28312755-A2F5-482E-85E1-94A01E22E8C7

P2860

Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.

http://www.wikidata.org/entity/Q45125308

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.

@en

Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.

@nl

type

label

Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.

@en

Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.

@nl

prefLabel

Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.

@en

Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.

@nl

P1433

Q45125308-131B7CBA-E1DB-4FE6-B29E-EC0D20F24919

P1476

Q45125308-0A59AAB1-C8FF-4498-9E94-9F9C48C5F051

P2093

Q45125308-017180AE-2FE7-474C-87BE-CE7840CAD09E

Q45125308-018B7FD0-B37C-4CB0-A0D3-38FF4A3493C4

Q45125308-1F834E34-515D-43C8-9C39-148D41D5A836

Q45125308-8DE67D6F-76D3-4BB4-AA11-63D2C401A840

Q45125308-C8E33C05-46FE-44EF-8FCF-11E086D9B108

Q45125308-DD427F05-8212-469A-B0C3-28459C18B16B

Q45125308-F908E3F8-DFC5-4195-B35B-F7E8BCB11E3C

P2860

Q45125308-046779EA-D558-4FEF-A656-CCF72C845EF0

Q45125308-F382D9A6-1291-4A0B-B081-68ECD36F1A27

P304

Q45125308-9E5D5B03-391A-448E-B175-CBC5D420C7FB

P31

Q45125308-5E161D53-8A5B-451A-823E-0BD0A1066C91

P356

Q45125308-B2C75299-362F-4948-8296-F40B870FBCC6

P433

Q45125308-7C9682A4-7E57-4455-9D95-ACB21BF2F231

P478

Q45125308-A5D175B9-87F9-421D-B2A2-A39A8DF9A038

P50

Q45125308-0615139C-A594-4160-9AE4-082F097E43A3

Q45125308-2FB1FE7D-0522-4790-97C7-6A8310470DB4

Q45125308-328E8377-1CB6-4260-948F-A1BEE24819C1

Q45125308-77293A7F-2AFA-4CB9-A156-38024F053FC4

Q45125308-8085C0D1-4EAC-40F9-8C7C-401DE674CB1E

Q45125308-FFD80380-5453-4993-82A6-EA93C4C26968

P577

Q45125308-DBACAB25-5F71-4F91-B808-F2468CA24F04

P698

Q45125308-2F9E541E-CFE9-4B3C-9E98-889AA9DC5236

P356

P1433

Annals of Neurology

P1476

Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.

@en

P2093

Agostino Baruzzi

http://www.w3.org/2001/XMLSchema#string

Bernd Wissinger

http://www.w3.org/2001/XMLSchema#string

Bruno Barbiroli

http://www.w3.org/2001/XMLSchema#string

Lora Longanesi

http://www.w3.org/2001/XMLSchema#string

Piero Barboni

http://www.w3.org/2001/XMLSchema#string

Simone Schimpf

http://www.w3.org/2001/XMLSchema#string

Valeria Clementi

http://www.w3.org/2001/XMLSchema#string

P2860

A clinicopathologic study of autosomal dominant optic atrophy.

No correlation between muscle A3243G mutation load and mitochondrial function in vivo.

P304

719-723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.20278

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Maria Lucia Valentino

Valerio Carelli

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15505825

http://www.w3.org/2001/XMLSchema#string